Literature DB >> 18779051

Antiretroelement activity of APOBEC3H was lost twice in recent human evolution.

Molly OhAinle1, Julie A Kerns, Melody M H Li, Harmit S Malik, Michael Emerman.   

Abstract

The primate APOBEC3 gene locus encodes a family of proteins (APOBEC3A-H) with various antiviral and antiretroelement activities. Here, we trace the evolution of APOBEC3H activity in hominoids to identify a human-specific loss of APOBEC3H antiviral activity. Reconstruction of the predicted ancestral human APOBEC3H protein shows that human ancestors encoded a stable form of this protein with potent antiviral activity. Subsequently, the antiviral activity of APOBEC3H was lost via two polymorphisms that are each independently sufficient to destabilize the protein. Nonetheless, an APOBEC3H allele that encodes a stably expressed protein is still maintained at high frequency, primarily in African populations. This stable APOBEC3H protein has potent activity against retroviruses and retrotransposons, including HIV and LINE-1 elements. The surprising finding that APOBEC3H antiviral activity has been lost in the majority of humans may have important consequences for our susceptibility to retroviral infections as well as ongoing retroelement proliferation in the human genome.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18779051      PMCID: PMC2608726          DOI: 10.1016/j.chom.2008.07.005

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  32 in total

1.  A comparison of bayesian methods for haplotype reconstruction from population genotype data.

Authors:  Matthew Stephens; Peter Donnelly
Journal:  Am J Hum Genet       Date:  2003-10-20       Impact factor: 11.025

2.  Whole-genome patterns of common DNA variation in three human populations.

Authors:  David A Hinds; Laura L Stuve; Geoffrey B Nilsen; Eran Halperin; Eleazar Eskin; Dennis G Ballinger; Kelly A Frazer; David R Cox
Journal:  Science       Date:  2005-02-18       Impact factor: 47.728

3.  APOBEC3 proteins inhibit human LINE-1 retrotransposition.

Authors:  Heide Muckenfuss; Matthias Hamdorf; Ulrike Held; Mario Perkovic; Johannes Löwer; Klaus Cichutek; Egbert Flory; Gerald G Schumann; Carsten Münk
Journal:  J Biol Chem       Date:  2006-05-30       Impact factor: 5.157

4.  Cellular inhibitors of long interspersed element 1 and Alu retrotransposition.

Authors:  Hal P Bogerd; Heather L Wiegand; Amy E Hulme; José L Garcia-Perez; K Sue O'Shea; John V Moran; Bryan R Cullen
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-25       Impact factor: 11.205

5.  Antiretroviral activity and Vif sensitivity of rhesus macaque APOBEC3 proteins.

Authors:  Cesar A Virgen; Theodora Hatziioannou
Journal:  J Virol       Date:  2007-10-17       Impact factor: 5.103

Review 6.  HIV-1 accessory proteins--ensuring viral survival in a hostile environment.

Authors:  Michael H Malim; Michael Emerman
Journal:  Cell Host Microbe       Date:  2008-06-12       Impact factor: 21.023

7.  Divergent patterns of recent retroviral integrations in the human and chimpanzee genomes: probable transmissions between other primates and chimpanzees.

Authors:  Patric Jern; Göran O Sperber; Jonas Blomberg
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

Review 8.  When less is more: gene loss as an engine of evolutionary change.

Authors:  M V Olson
Journal:  Am J Hum Genet       Date:  1999-01       Impact factor: 11.025

9.  Distribution of gene frequency as a test of the theory of the selective neutrality of polymorphisms.

Authors:  R C Lewontin; J Krakauer
Journal:  Genetics       Date:  1973-05       Impact factor: 4.562

10.  Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G.

Authors:  Sara L Sawyer; Michael Emerman; Harmit S Malik
Journal:  PLoS Biol       Date:  2004-07-20       Impact factor: 8.029

View more
  131 in total

Review 1.  HIV-1 Vif versus the APOBEC3 cytidine deaminases: an intracellular duel between pathogen and host restriction factors.

Authors:  Silke Wissing; Nicole L K Galloway; Warner C Greene
Journal:  Mol Aspects Med       Date:  2010-06-09

2.  Analysis of human APOBEC3H haplotypes and anti-human immunodeficiency virus type 1 activity.

Authors:  Xiaojun Wang; Aierken Abudu; Sungmo Son; Ying Dang; Patrick J Venta; Yong-Hui Zheng
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

3.  The activity spectrum of Vif from multiple HIV-1 subtypes against APOBEC3G, APOBEC3F, and APOBEC3H.

Authors:  Mawuena Binka; Marcel Ooms; Myeika Steward; Viviana Simon
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

4.  APOBEC3 proteins and genomic stability: the high cost of a good defense.

Authors:  Iñigo Narvaiza; Sébastien Landry; Matthew D Weitzman
Journal:  Cell Cycle       Date:  2012-01-01       Impact factor: 4.534

5.  The localization of APOBEC3H variants in HIV-1 virions determines their antiviral activity.

Authors:  Marcel Ooms; Susan Majdak; Christopher W Seibert; Ariana Harari; Viviana Simon
Journal:  J Virol       Date:  2010-06-02       Impact factor: 5.103

6.  Human and rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H demonstrate a conserved capacity to restrict Vif-deficient HIV-1.

Authors:  Judd F Hultquist; Joy A Lengyel; Eric W Refsland; Rebecca S LaRue; Lela Lackey; William L Brown; Reuben S Harris
Journal:  J Virol       Date:  2011-08-10       Impact factor: 5.103

7.  APOBEC3H polymorphisms associated with the susceptibility to HIV-1 infection and AIDS progression in Japanese.

Authors:  Daisuke Sakurai; Yasumasa Iwatani; Hitoshi Ohtani; Taeko K Naruse; Hiroshi Terunuma; Wataru Sugiura; Akinori Kimura
Journal:  Immunogenetics       Date:  2015-02-27       Impact factor: 2.846

8.  Identification of 81LGxGxxIxW89 and 171EDRW174 domains from human immunodeficiency virus type 1 Vif that regulate APOBEC3G and APOBEC3F neutralizing activity.

Authors:  Ying Dang; Roderick W Davis; Ian A York; Yong-Hui Zheng
Journal:  J Virol       Date:  2010-03-24       Impact factor: 5.103

9.  APOBEC3G restricts HIV-1 to a greater extent than APOBEC3F and APOBEC3DE in human primary CD4+ T cells and macrophages.

Authors:  Chawaree Chaipan; Jessica L Smith; Wei-Shau Hu; Vinay K Pathak
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

10.  The ssDNA Mutator APOBEC3A Is Regulated by Cooperative Dimerization.

Authors:  Markus-Frederik Bohn; Shivender M D Shandilya; Tania V Silvas; Ellen A Nalivaika; Takahide Kouno; Brian A Kelch; Sean P Ryder; Nese Kurt-Yilmaz; Mohan Somasundaran; Celia A Schiffer
Journal:  Structure       Date:  2015-04-23       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.